FAC Explorer

Audit 321915

FY End
2023-12-31
Total Expended
$3.00M
Findings
0
Programs
8
Organization: The Scintillon Institute (CA)
Year: 2023 Accepted: 2024-09-27
Auditor: Leaf & Cole LLP

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $810,485 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $355,999 Yes 0
93.837 Cardiovascular Diseases Research $260,985 Yes 0
93.859 Biomedical Research and Research Training $109,639 Yes 0
93.310 Trans-Nih Research Support $35,347 Yes 0
93.395 Cancer Treatment Research $15,290 Yes 0
93.855 Allergy, Immunology and Transplantation Research $-7,168 Yes 0
93.866 Aging Research $-8,301 Yes 0

Contacts

Name Title Type
WAADZMTALN67 Erica Chavin Auditee
7608896008 Jill Branch Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass-through entity identifying numbers are presented where available. De Minimis Rate Used: N Rate Explanation: The Scintillon Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance.